Floatz logo

Dfn-15

Survival Without Progression

Assistance Publique Hopitaux De MarseillePhase 2Dormant
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
41/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Survival Without Progression cohort.

Asset / SponsorPhaseRating
VINBLASTINE
Assistance Publique Hopitaux De Marseille
Phase 2B
METHOTREXATE
Assistance Publique Hopitaux De Marseille
Phase 2B
Cyclophosphamide
Assistance Publique Hopitaux De Marseille
Phase 2B

Same molecule, other indications

Dfn-15 is also rated in:

osteoarthritis, hipDormant
BB
Indicative ·
71 / 100
View asset →
osteoarthritis, kneeDormant
BB
Indicative ·
69 / 100
View asset →
ArthritisDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →